Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/9/2020
SIETES contiene 93101 citas

 
 
<< anterior 21 a 40 de 80 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Hayward CS, Webb CM, Collins P. Effect of sex hormones on cardiac mass. Lancet 2001;357:1354-6. [Ref.ID 58212]
22.Tiene citas relacionadas
Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki J D, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001;357:420-4. [Ref.ID 58028]
23.Tiene citas relacionadas
Grace AA, Brady PA, Shapiro LM. Risk management in hypertrophic cardiomyopathy. Lancet 2001;357:407-8. [Ref.ID 58027]
24.
Doll R. Review. Fifty years of research on tobacco. J Epidemiol Biostat 2000;5:321-9. [Ref.ID 56196]
25. Cita con resumen
Spirito P, Bellone P, Harris KM, Bernabò P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:1778-85. [Ref.ID 51448]
26.
Ferrari P, Bianchi G. The genomics of cardiovascular disorders. Drugs 2000;59:1025-42. [Ref.ID 50817]
27.Tiene citas relacionadas
Givertz MM. Underlying causes and survival in patients with heart failure. N Engl J Med 2000;342:1120-2. [Ref.ID 50412]
28.Tiene citas relacionadas Cita con resumen
Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-84. [Ref.ID 50407]
29.Tiene citas relacionadas
Kilian JG, Celermajer DS. Clozapine and sudden death. Authors' reply. Lancet 2000;355:843. [Ref.ID 49732]
30.Tiene citas relacionadas
Suttmann I, Ditter S, Landgraf R, Schulze J, Folwaczny C. Clozapine and sudden death. Lancet 2000;355:842-3. [Ref.ID 49731]
31.Tiene citas relacionadas
Warner B, Alphs L, Schaedelin J, Koestler T. Clozapine and sudden death. Lancet 2000;355:842. [Ref.ID 49730]
32.Tiene citas relacionadas
Chan NN. Clozapine and sudden death. Lancet 2000;355:841-2. [Ref.ID 49729]
33.Tiene citas relacionadas
Devarajan S, Kutcher SP, Dursun SM. Clozapine and sudden death. Lancet 2000;355:841. [Ref.ID 49728]
34.
Registre de trasplantament cardíac de Catalunya de l'Àrea Sanitària del Servei Català de la Salut. Activitat de trasplantament cardíac a Catalunya, 1984-1998. BEC 1999;20:167-71. [Ref.ID 49394]
35.Tiene citas relacionadas
Watkins H. Sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:422-4. [Ref.ID 49320]
36.Tiene citas relacionadas Cita con resumen
Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea R F, Boriani G, Estes III NAM, Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-73. [Ref.ID 49316]
38.
Lip GYH, Gibbs CR, Beevers DG. Aetiology. BMJ 2000;320:104-7. [Ref.ID 48736]
39. Cita con resumen
Kilian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999;354:1841-5. [Ref.ID 48310]
40.
Vance ML, Mauras N. Growth hormone therapy in adults and children. N Engl J Med 1999;341:1206-16. [Ref.ID 47231]
Seleccionar todas
 
<< anterior 21 a 40 de 80 siguiente >>